Advertisement
Heart, Lung and Circulation

Comparison of Health Related Quality of Life in Transcatheter Versus Surgical Aortic Valve Replacement: A Meta-Analysis

Published:August 16, 2018DOI:https://doi.org/10.1016/j.hlc.2018.07.013

      Background

      Data on the effects of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) on health-related quality of life (HRQOL) outcomes are limited. To assess the comparative HRQOL outcomes between TAVR and SAVR, we performed a systematic review and meta-analysis.

      Methods

      PubMed and EMBASE databases were searched for articles that compared the HRQOL scores, Kansas City Cardiomyopathy Questionnaire (KCCQ), Medical Outcomes Study Short-Form Health Survey 12 or 36 (SF-12/36), or the EuroQoL 5 Dimension score (EQ-5D) at 30 days and 1 year between TAVR and SAVR. Mean difference (MD) and 95% confidence interval (CI) was calculated with inverse variance statistical method and random-effects model.

      Results

      A total of four studies with 4,125 patients (1268 transfemoral [TF]-TAVR, 1261 Non-TF TAVR [transsubclavian, transapical or transaortic], and 1,596 SAVR) were included in the studies. KCCQ overall summary scores and its subscales, SF-12/36, and EQ-5D were significantly higher in TF-TAVR compared to SAVR but were similar in non-TF TAVR vs. SAVR at 30 days. At 1-year follow-up, TF-TAVR and non-TF TAVR conferred similar HRQOL scores in KCCQ overall summary and subscales scores, SF-12/36, and EQ-5D compared to SAVR.

      Conclusions

      Transfermoral-TAVR achieved better HRQOL at 30 days but similar HRQOL at 1 year compared to SAVR. Non-TF TAVR resulted in similar improvements in HRQOL at both 30 days and 1 year compared with SAVR.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mack M.J.
        • Leon M.B.
        • Smith C.R.
        • Miller D.C.
        • Moses J.W.
        • Tuzcu E.M.
        • et al.
        5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
        Lancet. 2015; 385: 2477-2484
        • Brennan J.M.
        • Thomas L.
        • Cohen D.J.
        • Shahian D.
        • Wang A.
        • Mack M.J.
        • et al.
        Transcatheter versus surgical aortic valve replacement: propensity-matched comparison.
        J Am Coll Cardiol. 2017; 70: 439-450
        • Deeb G.M.
        • Reardon M.J.
        • Chetcuti S.
        • Patel H.J.
        • Grossman P.M.
        • Yakubov S.J.
        • et al.
        3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement.
        J Am Coll Cardiol. 2016; 67: 2565-2574
        • Reardon M.J.
        • Van Mieghem N.M.
        • Popma J.J.
        • Kleiman N.S.
        • Søndergaard L.
        • Mumtaz M.
        • et al.
        Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.
        N Engl J Med. 2017; 376: 1321-1331
        • Arnold S.V.
        • Spertus J.A.
        • Vemulapalli S.
        • Li Z.
        • Matsouaka R.A.
        • Baron S.J.
        • et al.
        Quality-of-life outcomes after transcatheter aortic valve replacement in an unselected population: a report from the STS/ACC transcatheter valve therapy registry.
        JAMA Cardiol. 2017; 2: 409-416
        • Tokarek T.
        • Siudak Z.
        • Dziewierz A.
        • Sobczyński R.
        • Zasada W.
        • Sorysz D.
        • et al.
        Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement.
        Catheter Cardiovasc Interv. 2016; 88: E80-E88
        • Lange R.
        • Beckmann A.
        • Neumann T.
        • Krane M.
        • Deutsch M.A.
        • Landwehr S.
        • et al.
        Quality of life after transcatheter aortic valve replacement: prospective data from GARY (German Aortic Valve Registry).
        JACC Cardiovasc Interv. 2016; 9: 2541-2554
        • Kappetein A.P.
        • Head S.J.
        • Généreux P.
        • Piazza N.
        • van Mieghem N.M.
        • Blackstone E.H.
        • et al.
        Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
        J Am Coll Cardiol. 2012; 60: 1438-1454
        • Green C.P.
        • Porter C.B.
        • Bresnahan D.R.
        • Spertus J.A.
        Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.
        J Am Coll Cardiol. 2000; 35: 1245-1255
        • Arnold S.V.
        • Spertus J.A.
        • Lei Y.
        • Allen K.B.
        • Chhatriwalla A.K.
        • Leon M.B.
        • et al.
        Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis.
        Circ Heart Fail. 2013; 6: 61-67
        • Ware Jr, J.E.
        • Sherbourne C.D.
        The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
        Med Care. 1992; 30: 473-483
        • Ware Jr, J.
        • Kosinski M.
        • Keller S.D.
        A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.
        Med Care. 1996; 34: 220-233
        • Failde I.
        • Ramos I.
        Validity and reliability of the SF-36 Health Survey Questionnaire in patients with coronary artery disease.
        J Clin Epidemiol. 2000; 53: 359-365
        • Failde I.
        • Medina P.
        • Ramirez C.
        • Arana R.
        Construct and criterion validity of the SF-12 health questionnaire in patients with acute myocardial infarction and unstable angina.
        J Eval Clin Pract. 2010; 16: 569-573
        • Shaw J.W.
        • Johnson J.A.
        • Coons S.J.
        US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
        Med Care. 2005; 43: 203-220
        • Reynolds M.R.
        • Magnuson E.A.
        • Wang K.
        • Thourani V.H.
        • Williams M.
        • Zajarias A.
        • et al.
        Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).
        J Am Coll Cardiol. 2012; 60: 548-558
        • Arnold S.V.
        • Reynolds M.R.
        • Wang K.
        • Magnuson E.A.
        • Baron S.J.
        • Chinnakondepalli K.M.
        • et al.
        Health status after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: results from the CoreValve US pivotal trial.
        JACC Cardiovasc Interv. 2015; 8: 1207-1217
        • Gada H.
        • Kirtane A.J.
        • Wang K.
        • Lei Y.
        • Magnuson E.
        • Reynolds M.R.
        • et al.
        Temporal trends in quality of life outcomes after transapical transcatheter aortic valve replacement: a placement of AoRTic TraNscathetER valve (PARTNER) trial substudy.
        Circ Cardiovasc Qual Outcomes. 2015; 8: 338-346
        • Baron S.J.
        • Arnold S.V.
        • Wang K.
        • Magnuson E.A.
        • Chinnakondepali K.
        • Makkar R.
        • et al.
        Health status benefits of transcatheter vs surgical aortic valve replacement in patients with severe aortic stenosis at intermediate surgical risk: results from the PARTNER randomized clinical trial.
        JAMA Cardiol. 2017; 2: 837-845
        • Smith C.R.
        • Leon M.B.
        • Mack M.J.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • et al.
        Transcatheter versus surgical aortic-valve replacement in high-risk patients.
        N Engl J Med. 2011; 364: 2187-2198
        • Leon M.B.
        • Smith C.R.
        • Mack M.J.
        • Makkar R.R.
        • Svensson L.G.
        • Kodali S.K.
        • et al.
        Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.
        N Engl J Med. 2016; 374: 1609-1620
        • Soto G.E.
        • Jones P.
        • Weintraub W.S.
        • Krumholz H.M.
        • Spertus J.A.
        Prognostic value of health status in patients with heart failure after acute myocardial infarction.
        Circulation. 2004; 110: 546-551
        • Chan P.S.
        • Soto G.
        • Jones P.G.
        • Nallamothu B.K.
        • Zhang Z.
        • Weintraub W.S.
        • et al.
        Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS).
        Circulation. 2009; 119: 398-407
        • Grover F.L.
        • Vemulapalli S.
        • Carroll J.D.
        • Edwards F.H.
        • Mack M.J.
        • Thourani V.H.
        • et al.
        2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
        J Am Coll Cardiol. 2017; 69: 1215-1230